Diseases List

ID 45
Name IRRITABLE BOWEL SYNDROME
Cause
Signs Symptoms
Diagnosis
Investigations Investigations: In I.B.S the findings of investigations are usually normal. So, it is of no value to do a lot of tests. In most young patients diagnosis can confidently be^ made on clinical presentations. But, older patients coming with abdominal pain or diarrhoea must be investigated before diagnosing as I.B.S. However, in most cases suspecting as I.B.S some routine and special investigations are done to exclude any organic disease or gynaecological involvement. Routine investigations: 1. Complete blood count & ESR 2. Serological tests (as indicated) 3. Serum albumin 4. Stool- Routine & occult blood test 5. Sigmoidoscopy Special investigations: (to be done as indicated) 1. Ba-enema or colonoscopy- to exclude colorectal cancer or inflammatory bowel disease usually in patients of age over 40 yrs. 2. Ultrasonography of abdominal & pelvic organs- to exclude any organic or gynaecological involvement. 3. Radiological investigations. 4. Test for lactose intolerence. Or, 5. Test for bile acid malabsorption.
Management 1. Reassurance- in most patients where symptoms are not severe and stress-related, reassurance might be sufficient. 2. Patients with diarrhoea predominent: i. For pain & diarrhoea- an anticholinergic drug such as- hyoscyamine 0.125mg orally or sustained-release preparation 0.37mg or 0.75mg orally twice daily; or dicyclomine 10- 20mg or mebeverine hydrochloride 135mg (1 tablet) beore meals and at bedtime, may help to control symptoms. Alosetron, a 5-HT3 antagonist, alters gastrointestinal visceral sensation & colonic motility through blockade of peripheral 5-HT3-receptors, so, it is approved for the treatment of women with severe irnitable bowel syndrome with predominant diarrhoea. Alosetron 0.5-lmg twice daily reduces symptoms of pain, cramps, urgency, & diarrhoea in 50-60% of women. But, as alosetron may cause severe constipation (about 30%), or ischemic colitis (4:1000), the use of alosetron is restricted to women with severe IBS with diarrhoea, who have not responded to conventional therapies. ii. Patient should avoid lxatives, legumes and excessive dietary fibre. iii. If diarrhoea persists- Loperamide 2mg orally 3 to 4 times daily; or Codeine phosphate 30-90mg daily or colestyramine 1 sachet daily. 3. Patients with constipation predominent: i. The patient should be encouraged to have high-roughage diet, ii. If constipation persists- Osmotic laxatives such as- milk of magnesia or polyethylene glycol may increase stool frequency and improve stool consistency. Lactulose or sorbitol produces increased flatus and distention, so that these are less advisable in irritable bowel syndrome. 4. In case of acute episodes of pain and bloating- spasmolytic drugs such as, dicyclomine or hyoscyamine or mebeverine may be advised. 5. Dietary restriction, particularly the avoidance of fresh fruits and salads. Specific foods which cause or enhance irritable condition should be avoided. 6. Nonabsorbable antibiotics: Although, the use of antibiotics in irritable bowel syndrome is controversial, in case of bacterial overgrowth (if any), a nonabsorbale antibiotic- rifaximin 400mg 3 times daily for 10 days, play a role in improvement of symptoms in about 40% of patients. This inprovenent may be attributable to suppression of bacteria in either the small intestine or colon. 7. Psychotherapy may be helpful in case of anxiety & depression, if identified. Patients with predominant diarrhoea associated with psychosocial factors, may benefit from low doses of tricyclic-type antidepressants, such as amitriptyline 10-25mg or nortriptyline, desipramine, imipramine or trazodone 25mg at bedtime, may be increased gradually to 50-100mg. In patients with predominant constipation associated with psychosocial factors, drugs commonly used are sertraline 50-150mg daily or fluoxetine 20-40mg daily at morning. Improvement usually expected within 4 weeks. In chronic anxiety- an antianxiety drug e.g alprazolam 0.25mg 2 or 3 times daily may be beneficial.
Introduction Irritable bowel syndrome can be defined as a functional bowel disorder characterized by a variable chronic or recurrent gastrointestinal symptoms essentially associated with abdominal pain and altered bowel habits. The symptoms can not be explained by structural or biochemical abnormalities. Usual age incidence- late teens to 40 years; women are more frequently affected than men.
History
Etiology Etiology2: As it is a syndrome, a single cause is unlikely. On the other hand no definite or organic cause can be evaluated. Some factors are believed to be associated with the etiology of I.B.S 1. Psychosocial factors - about 50% patients are found to be associated with this problems, such as anxiety, depression, somatisation, neurosis, panic attacks, acute psychological stress etc. 2. Altered gastrointestinal motility - some motility disorders are found but non is diagnostic. 3. Abnormal visceral perception - I.B.S may be associated with increased sensitivity to intestinal distension. 4. Luminal factors - such as following gastroenteritis, dietary intolerence e.g wheat, dairy products etc
Clinical Features Clinical feature: Patient of I.B.S commonly presents with- 1. Abdominal pain referred to the left or right iliac fossa or to the hypogastrium, usually colicky or cramping, diffuse or localised and rarely severe. It is generally relieved by defaecation or with the passage of wind, and is sometimes provoked by food. Pain may be associated with constipation, the stools being hard and pellet like & accompanied by mucous, but rectal bleeding does not occur. Tenderness is common over the pelvic colon. 2. In I.B.S, diarrhoea & alternate constipation is a common phenomenon. Diarrhoea occurs characteristically in the morning; patient usually complaints of passage of frequent small volume stools & a feeling of incomplete emptying of the rectum. 3. Abdominal distension or bloating is very common. 4. Nausea, anorexia, tiredness & weakness occur. Vomiting is common. But patients don’t loss weight 5. Varying degrees of anxiety or depression is present. Patient may also have other functional complaints such as heartburn, chest pain, fatigue, urologic dysfunction, and gynaecologic problems.
Preventions
Treatment
Complications
Prognosis
Types
Classification
Observation
Pathology
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406